NCT04938986Recruiting
Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer
Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer : Prospective Cohort Comparing the Recommandation for Patient Care According to the Immunoscore® With the Standard Care Decision.
Source: ClinicalTrials.gov · Last updated 13 Apr 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Evaluate the patient care recommandation induced by the IMMUNOSCORE® result
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 22 Jun 2021
- Start date
- 4 Apr 2022
- Primary completion date
- Apr 2028
- Lead sponsor
- Hospital St. Joseph, Marseille, France
- Diseases
- Colorectal cancer
- NCT number
- NCT04938986
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 4 Apr 2022 to the primary completion date, Apr 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- legal incapacity or physical, psychological, social or geographical conditions preventing the patient from signing the consent or completing the study.
- history of other solid tumor within 3 years before inclusion, with the exception of in-situ cancer of the cervix and skin cancers (basal or squamous) treated and controlled
Other
- pregnant or breastfeeding women
- person subject to a safeguard measure.
Who the study is looking for
- age between 18 and 80 inclusive;
- histologically confirmed colon adenocarcinoma;
- having undergone a curative resection of stage I, II or III colorectal cancer;
- diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2;
- eligible to receive 6 months of adjuvant chemotherapy;
- having given free, informed and written consent;
- agreeing to the use of a tumor sample for research purposes;
- being affiliated to a social security system.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Saint Joseph Coordinator of this site? Confirm its status | Marseille | France | Recruiting |
| Hopital Europeen Coordinator of this site? Confirm its status | Marseille | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.